1 month Medpace (NASDAQ:MEDP) Cut to “Neutral” at Robert W. BairdMarketBeat
Robert W. Baird downgraded shares of Medpace from an “outperform” rating to a “neutral” rating and cut their target price for the stock from $413.00 to $349.00 in a research report on Wednesday.
X